Skip to content
Lifestyle

Testosterone After 50: The Complete Guide to Staying Optimized

12 min read
#testosterone after 50#aging and testosterone#prostate health#TRT for older men#resistance training over 50

After 50, the testosterone conversation changes. The numbers matter less than the context: body weight, other health conditions, medications, and what treatment would mean for your prostate and heart. This guide summarizes what large studies show about testosterone in men over 50, what is associated with lower levels, and how doctors approach treatment decisions. It is educational information, not medical advice.

Key takeaways

In healthy non-obese men aged 50 to 59, median total testosterone was about 477 ng/dL, and the upper end of the range barely differed from younger men, while the lower end was lower.[1]

In 3,200 European men aged 40 to 79, a BMI of 30 or more was associated with 5.09 nmol/L (about 147 ng/dL) lower total testosterone than a BMI under 25.[2]

In the TRAVERSE trial of 5,246 men aged 45 to 80, major cardiovascular events occurred in 7.0 percent on testosterone and 7.3 percent on placebo, but atrial fibrillation, acute kidney injury and pulmonary embolism were more common with testosterone.[3]

A meta-analysis found resistance training did not significantly change basal testosterone in men aged 60 and older,[4] though WHO recommends regular muscle-strengthening activity for all adults for general health.[5]

~477 ng/dL
Median total testosterone in healthy, non-obese men aged 50 to 59
Middle 90% of values: about 256 to 839 ng/dL (harmonized data, 4 cohorts)

What Is Associated with Lower Testosterone After 50

Popular articles claim that testosterone falls off a cliff after 50. The data are more nuanced. In harmonized data, median total testosterone in non-obese men is about 481 ng/dL at ages 40 to 49 and about 477 ng/dL at ages 50 to 59, 60 to 69 and 70 to 79, and the upper percentiles barely change with age while the lower percentiles fall.[1] Longitudinal data from Massachusetts (men aged 40 to 70 at baseline) found total testosterone declined about 1.6 percent per year within men over 7 to 10 years, and bioavailable testosterone about 2 to 3 percent per year, with SHBG rising about 1.6 percent per year in cross-sectional comparisons.[6]

The European Male Aging Study gives the best picture of what is linked to lower levels. In 3,200 men aged 40 to 79, age was associated with lower free testosterone and raised LH (suggesting reduced testicular function), obesity with lower total and free testosterone and unchanged or lower LH (suggesting hypothalamic or pituitary effects), and comorbid conditions with lower total testosterone. The authors concluded that some risk factors are potentially modifiable and may help maintain testosterone during aging.[2]

Medications can matter too. A 2025 review describes chronic opioid use as a common but underappreciated cause of androgen deficiency in men.[7] If you take opioids for chronic pain and have symptoms, raise it with your prescriber. Men considering GLP-1 weight loss drugs should also read about the muscle loss and testosterone implications. For more on how the hormone axis works, see our HPG axis guide and our article on estrogen in men.

Prostate Health and the Saturation Model

For decades, the working assumption was that more testosterone means more prostate cancer risk, because removing testosterone shrinks advanced prostate cancer. A 2009 review proposed a saturation model as a framework: prostate cancer growth is very sensitive to androgen changes at very low concentrations, but becomes insensitive at higher levels, because androgen receptor binding is maximal at serum testosterone concentrations well below the physiologic range.[8] It is a conceptual model proposed by its authors, and it is still discussed among urologists.

What the TRAVERSE prostate data show

In TRAVERSE, among men carefully screened to exclude those at high risk of prostate cancer, the incidence of high-grade or any prostate cancer, acute urinary retention, prostate procedures and new treatment for urinary symptoms was low and did not differ between testosterone and placebo. PSA rose more on testosterone than on placebo in the first year. The authors recommend a baseline evaluation of prostate cancer risk and a standardized monitoring plan.[9]

This does not mean testosterone is irrelevant to prostate health. The Endocrine Society recommends against starting testosterone therapy in men with prostate cancer, a palpable prostate nodule or induration, a PSA above 4 ng/mL (or above 3 ng/mL in men at higher risk) without further urological evaluation, or severe lower urinary tract symptoms.[10] For a deeper look, see our article on testosterone and prostate health.

Cardiovascular Considerations

Earlier observational studies raised concerns about cardiovascular risk with testosterone therapy in older men. The TRAVERSE trial was designed to answer the question. It randomly assigned 5,246 men aged 45 to 80 who had symptoms of hypogonadism, two fasting testosterone levels below 300 ng/dL, and preexisting or high risk of cardiovascular disease to testosterone gel or placebo. With a mean follow-up of 33 months, the primary event (cardiovascular death, nonfatal heart attack or nonfatal stroke) occurred in 7.0 percent of men on testosterone and 7.3 percent on placebo (hazard ratio 0.96), meeting the prespecified noninferiority criterion. A higher incidence of atrial fibrillation, acute kidney injury and pulmonary embolism was observed in the testosterone group.[3]

So the evidence is reassuring on heart attack and stroke in this population, but not a clean bill of health. The Endocrine Society also lists elevated hematocrit, uncontrolled heart failure, and a heart attack or stroke in the last 6 months among reasons not to start therapy.[10] Regular blood pressure, lipid and hematocrit checks are sensible at this age regardless of testosterone, and anyone with heart disease should work with their cardiologist. See our article on testosterone and cardiovascular health.

Exercise After 50: Realistic Expectations

A systematic review and meta-analysis of 22 studies in men aged 60 and older found that resistance training did not significantly influence basal testosterone (standardized difference in means about 0), while endurance and interval training were associated with small but significant increases. The authors described the effect as small and noted the evidence is limited.[4] That does not make strength training pointless. The WHO 2020 guidelines recommend regular muscle-strengthening activity for all age groups, along with 150 to 300 minutes of moderate-intensity aerobic activity per week for adults.[5] The benefits of resistance training are mostly about strength, function and metabolic health, with any change in testosterone a possible bonus rather than a promise.

✓ Do This

  • •Compound movements built up gradually (squats, presses, rows)
  • •Warm-ups that prepare joints and connective tissue
  • •Rest days between hard sessions
  • •Checking with a doctor first if you have heart disease or joint problems

✗ Not This

  • •Training through joint pain or ignoring injury signals
  • •Maximum-effort lifts without a build-up phase
  • •Training hard every day without recovery
  • •Copying programs designed for young competitive lifters

Sleep, Weight and Protein

Sleep quality often changes with age, and conditions such as sleep apnea become more common. Sleep apnea matters for testosterone treatment too: testosterone therapy may worsen untreated sleep apnea,[11] and the Endocrine Society lists untreated severe obstructive sleep apnea among reasons not to start it.[10] If you snore loudly, wake unrefreshed or stop breathing at night, ask a doctor about a sleep study. Weight matters too: see our guide to low testosterone and weight gain.

Protein needs change with age as well. A PROT-AGE position paper recommends that older people (over 65) average at least 1.0 to 1.2 grams of protein per kilogram of body weight per day, and more if exercising, with an exception for people with severe kidney disease who may need to limit protein.[12] Check with your doctor if you have kidney problems. See our guide on protein and testosterone for more.

How Doctors Approach TRT Decisions

The steps below summarize what the major guidelines describe. They are not a self-treatment plan. Any testosterone therapy should be prescribed and monitored by a doctor.

Guideline-Based Steps for Men Over 50

Step 1

Confirm with repeat morning testing

The AUA guideline calls a total testosterone below 300 ng/dL a reasonable cut-off and requires two early-morning measurements together with symptoms or signs. The Endocrine Society likewise advises fasting morning tests, repeated to confirm. One low reading is not a diagnosis.

Step 2

Look for causes

If testosterone is confirmed low, guidelines recommend evaluating the cause. Obesity, other illnesses, sleep apnea and medications such as opioids can all be involved, and treating these may matter more than hormones.

Step 3

Weigh realistic benefits and risks

In the Testosterone Trials (790 men aged 65 and older with low testosterone), treatment moderately improved sexual function and slightly improved mood, with no benefit for vitality or walking distance. TRAVERSE showed no excess of major cardiovascular events but more atrial fibrillation, acute kidney injury and pulmonary embolism.

Step 4

Baseline prostate and heart assessment

The Endocrine Society recommends against starting therapy in men with prostate cancer, elevated PSA without evaluation, elevated hematocrit, untreated severe sleep apnea or recent heart attack or stroke, among others. Your doctor will screen for these.

Step 5

Monitor if treatment starts

Guidelines call for a standardized monitoring plan covering symptoms, side effects, testosterone and hematocrit levels, and prostate cancer risk. Follow your doctor's schedule.

Citations for these steps: AUA guideline,[13] Endocrine Society guideline,[10] the Testosterone Trials[14] and TRAVERSE.[3]

A Note on Supplements

Most testosterone supplements have weak evidence at any age. Rather than guessing, ask your doctor whether blood tests show a deficiency in vitamin D or other nutrients, and check for interactions with any medications you take. Our guide to zinc and magnesium covers what the research says about those two.

The Bottom Line

Testosterone after 50 is about context. Typical levels are somewhat lower than in younger men, but the spread is wide, and body weight, other conditions and medications are among the factors linked to lower levels. Exercise, healthy weight and good sleep are recommended for health in their own right. If you have persistent symptoms, see a doctor for repeat morning testing, and if treatment is discussed, make sure prostate, heart, hematocrit and sleep apnea status are all part of the conversation. For the next decade, our guide on testosterone after 60 covers the additional considerations.

How Thrive Helps

Thrive is a habit-tracking app that helps you build consistent routines around training, sleep, nutrition and stress, the everyday factors discussed above. Thrive is a wellness app, not a medical device, and it does not diagnose or treat any condition or replace medical advice. Try Thrive free.

References

  1. Travison TG, Vesper HW, Orwoll E, et al.. Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe. J Clin Endocrinol Metab. 2017. doi.org/10.1210/jc.2016-2935
  2. Wu FC, Tajar A, Pye SR, et al.. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. 2008. doi.org/10.1210/jc.2007-1972
  3. Lincoff AM, Bhasin S, Flevaris P, et al.. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023. doi.org/10.1056/NEJMoa2215025
  4. Hayes LD, Elliott BT. Short-term exercise training inconsistently influences basal testosterone in older men: a systematic review and meta-analysis. Front Physiol. 2018. doi.org/10.3389/fphys.2018.01878
  5. Bull FC, Al-Ansari SS, Biddle S, et al.. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020. doi.org/10.1136/bjsports-2020-102955
  6. Feldman HA, Longcope C, Derby CA, et al.. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2002. doi.org/10.1210/jcem.87.2.8201
  7. Kafel H, Braga-Basaria M, Basaria S. Opioid-induced androgen deficiency in men: prevalence, pathophysiology, and efficacy of testosterone therapy. Andrology. 2025. doi.org/10.1111/andr.70013
  8. Morgentaler A, Traish AM. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol. 2009. doi.org/10.1016/j.eururo.2008.09.024
  9. Bhasin S, Thompson IM. Prostate risk and monitoring during testosterone replacement therapy. J Clin Endocrinol Metab. 2024. doi.org/10.1210/clinem/dgae334
  10. Bhasin S, Brito JP, Cunningham GR, et al.. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018. doi.org/10.1210/jc.2018-00229
  11. Fui MN, Dupuis P, Grossmann M. Lowered testosterone in male obesity: mechanisms, morbidity and management. Asian J Androl. 2014. doi.org/10.4103/1008-682X.122365
  12. Bauer J, Biolo G, Cederholm T, et al.. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013. doi.org/10.1016/j.jamda.2013.05.021
  13. Mulhall JP, Trost LW, Brannigan RE, et al.. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018. doi.org/10.1016/j.juro.2018.03.115
  14. Snyder PJ, Bhasin S, Cunningham GR, et al.. Effects of testosterone treatment in older men. N Engl J Med. 2016. doi.org/10.1056/NEJMoa1506119

Frequently Asked Questions

Evidence is limited. In a European study of 3,200 men aged 40 to 79, obesity was associated with substantially lower total and free testosterone, and a longitudinal analysis found that weight loss was associated with a rise in testosterone. A meta-analysis of studies in men aged 60 and over found that resistance training did not significantly change basal testosterone, though aerobic and interval training showed small increases. Exercise and weight management are still recommended for overall health, and a doctor can help you interpret your own results.
In harmonized data from four cohort studies, healthy non-obese men aged 50 to 59 had a median total testosterone of about 477 ng/dL, with the middle 90 percent of values between roughly 256 and 839 ng/dL. Among all men aged 50 to 59 (including those with obesity), the median was about 446 ng/dL. Ranges vary by lab, and a diagnosis of low testosterone requires symptoms plus repeated low morning results, not a single number.
Testosterone therapy is a medical decision for men with symptoms and consistently low morning testosterone confirmed by a doctor. In the TRAVERSE trial of 5,246 men aged 45 to 80, testosterone gel was noninferior to placebo for major cardiovascular events (7.0 versus 7.3 percent), but atrial fibrillation, acute kidney injury and pulmonary embolism were more common with testosterone. Guidelines call for prostate and hematocrit evaluation before and during treatment. Discuss benefits and risks with an endocrinologist or urologist.

Ready to optimize?

Turn evidence into action. Download THRIVE Male Health and start building science-backed habits today.

Download Thrive